Litigation Details for JANSSEN PRODUCTS, L.P. v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2020)

JANSSEN PRODUCTS, L.P. v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2020)

Docket		Date Filed	2020-01-22
Court	District Court, D. New Jersey	Date Terminated	2020-06-19
Cause	35:271 Patent Infringement	Assigned To	Freda L. Wolfson
Jury Demand	None	Referred To	Tonianne J. Bongiovanni
Patents	7,700,645; 8,518,987
Link to Docket	External link to docket

Details for JANSSEN PRODUCTS, L.P. v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
2020-01-22	1	Complaint	Defendants of U.S. Patent Nos. 7,700,645 (the “’645 Patent”) and 8,518,987 (the “’987 Patent”) arising under… the ’645 Patent, ’987 Patent, the ’015 Patent, and the ’408 Patent (together, the “patents-in-suit”)… PageID: 2 Patent Nos. 7,126,015 (the “’015 Patent”) and 7,595,408 (the “’408 Patent”) under 35 U.S.C…April 20, 2010, the U.S. Patent and Trademark Office (“PTO”) issued the ’645 Patent, entitled “Pseudopolymorphic… holds title to the ’645 Patent. 38. The ’645 Patent expires on December 26, 2026	External link to document
2020-06-19	13	Judgment - Consent	United States Patent Nos. 7,700,645 (the “’645 Patent”); 8,518,987 (the “’987 Patent”); 7,126,015 …the “’015 Patent”); and 7,595,408 (the “’408 Patent”) (collectively, the “Janssen Patents”); …each of the Janssen Patents, including any patent term extensions and/or patent term adjustments and… the Janssen Patents would constitute acts of infringement of the Janssen Patents; WHEREAS… the Janssen Patents would constitute acts of infringement of the Janssen Patents, absent authorization	External link to document